Search Results - "Jaskowiak, C"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    TH‐C‐201C‐02: Impact of Image Acquisition Mode and Reconstruction Parameters on Target Volume Definition Using PET‐Thresholded‐Based Segmentation by Galavis, P, Jallow, N, Jaskowiak, C, Paliwal, B, Jeraj, R

    Published in Medical Physics (01-06-2010)
    “…Purpose: Although PET‐threshold‐based tumor segmentation has been investigated extensively for target definition in radiotherapy the sensitivity of this method…”
    Get full text
    Conference Proceeding Journal Article
  2. 2

    SU‐DD‐A4‐02: Potential Improvement of PET Imaging Quantitative Accuracy with An External Reference Source by Song, C, Jaskowiak, C, Pyzalski, R, Jeraj, R

    Published in Medical Physics (01-06-2009)
    “…Purpose: PET has been increasingly used to assess therapeutic response. As PET suffers from many inaccuracies, it might be difficult to distinguish between…”
    Get full text
    Conference Proceeding Journal Article
  3. 3

    SU‐GG‐J‐139: Quantitative PET Imaging of Heterogeneous Tumors: The Dosimetric Effect of Patient Motion on Image‐Based Dose Painting Plans by McCall, K, Bowen, S, Jaskowiak, C, McNall, M, Rice, S, Jeraj, R

    Published in Medical Physics (01-06-2010)
    “…Purpose: Dose‐painting requires accurate quantification of tumor characteristics and precise localization of molecular targets within tumors. Imaging with PET…”
    Get full text
    Conference Proceeding Journal Article
  4. 4

    WE‐D‐ValB‐01: Effects of PET Reconstruction Parameters On the Delineation of Heterogeneous Target Volumes by Barbee, D, Flynn, R, Jaskowiak, C, Jeraj, R

    Published in Medical Physics (01-06-2006)
    “…Purpose As emerging radiotherapy techniques incorporate biological targeting of sub‐tumor volumes, steps must be taken to ensure the validity of the assumed…”
    Get full text
    Conference Proceeding Journal Article
  5. 5

    TH‐E‐ValB‐04: Dosimetric Impact of Changed FLT Uptake in AML Patients Treated with Chemotherapy by Vanderhoek, M, Pyzalski, R, Jaskowiak, C, Jeraj, R

    Published in Medical Physics (01-06-2006)
    “…Purpose: The PET radiotracer [F‐18]FLT (3′‐deoxy‐3′‐[F‐18]fluorothymidine), used to measure cellular proliferation, has the potential to validate the efficacy…”
    Get full text
    Conference Proceeding Journal Article
  6. 6

    SU‐GG‐AUD‐03: The Development and Validation of An Image‐Based Dosimetry System for 90Y Microspheres Used to Treat Hepatic Tumors by Selwyn, R, Jaskowiak, C, Nickles, R, McDermott, J, Welsh, J, DeWerd, L, Thomadsen, B

    Published in Medical physics (Lancaster) (01-06-2007)
    “…Purpose: To develop and experimentally validate an image‐based dosimetry system for determining the three‐dimensional (3D) dose distribution from 90 Y…”
    Get full text
    Journal Article
  7. 7

    TU‐C‐J‐6B‐03: Deformable Fusion of 4D PET Images by Zhang, T, Pyzalski, R, Jaskowiak, C, Tome, W, Mackie, T, Paliwal, B

    Published in Medical physics (Lancaster) (01-06-2005)
    “…Purpose: PET images are useful in defining treatment targets. Removing distortion from respiratory motion in the PET images is of importance for gated or 4D…”
    Get full text
    Journal Article
  8. 8

    Assessing environmental chemical uptake in fetal brain in utero: A preliminary PET/CT study by DeJesus, O. T., Flores, L. G., Converse, A. K., Bartlett, R. M., Murali, D., Jeraj, R., Oakes, T. R., Nickles, R. J., Jaskowiak, C. J.

    “…Exposure to several environmental chemicals in utero is associated with subtle deleterious effects in cognitive, motor and behavioral functions. In order to…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    18F-labeled resin microspheres as surrogates for 90Y resin microspheres used in the treatment of hepatic tumors: a radiolabeling and PET validation study by Selwyn, R G, Avila-Rodriguez, M A, Converse, A K, Hampel, J A, Jaskowiak, C J, McDermott, J C, Warner, T F, Nickles, R J, Thomadsen, B R

    Published in Physics in medicine & biology (21-12-2007)
    “…(90)Y-labeled resin microspheres (SIR-Spheres) are currently used to treat patients with primary and metastatic solid liver tumors. This treatment is typically…”
    Get more information
    Journal Article